📡AI Signal

Snapshot — April 16, 2026

3 stories

← April 15, 2026April 17, 2026 →
OpenAI GPT-Rosalind Targets Life Sciences Research
April 16, 2026
OpenAI introduced GPT-Rosalind, a life-sciences-tuned model built for biological research, drug discovery, and tool-heavy scientific workflows. It is OpenAI's most explicit vertical research model to date and complements ChatGPT and the Agents SDK as the company reorients toward enterprise and scientific applications.
OpenAI's GPT-5.5 is a fully retrained base — the first since GPT-4.5 — claiming the top of the Artificial Analysis Intelligence Index at 60, scoring 82.7% on…
April 16, 2026
  • OpenAI's GPT-5.5 is a fully retrained base — the first since GPT-4.5 — claiming the top of the Artificial Analysis Intelligence Index at 60, scoring 82.7% on Terminal-Bench 2.0 (+7.6 over GPT-5.4), and finishing Codex tasks with ~40% fewer output tokens.
  • API pricing doubled to $5/$30 per MTok ($30/$180 for the Pro variant); effective cost is up only ~20% after token-efficiency gains.
V4 Pro is a 2T-parameter MoE (49B active) with a 1M context, GPQA 90.1, and SWE-bench 80.6 at $1.74/$3.48 per MTok.
April 16, 2026
  • V4 Pro is a 2T-parameter MoE (49B active) with a 1M context, GPQA 90.1, and SWE-bench 80.6 at $1.74/$3.48 per MTok.
  • V4 Flash (284B/13B) targets latency-sensitive workloads at $0.14/$0.28.
  • The release lands the same week as GPT-5.5 and tightens open-weights' gap with frontier closed models.
← April 15, 2026April 17, 2026 →